SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-21-011033
Filing Date
2021-05-11
Accepted
2021-05-11 16:30:49
Documents
92
Period of Report
2021-03-31

Document Format Files

Seq Description Document Type Size
1 form10-q.htm   iXBRL 10-Q 1085687
2 ex31-1.htm EX-31.1 17205
3 ex31-2.htm EX-31.2 17147
4 ex32-1.htm EX-32.1 9295
  Complete submission text file 0001493152-21-011033.txt   7011300

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE hrow-20210331.xsd EX-101.SCH 60478
6 XBRL CALCULATION FILE hrow-20210331_cal.xml EX-101.CAL 80629
7 XBRL DEFINITION FILE hrow-20210331_def.xml EX-101.DEF 323292
8 XBRL LABEL FILE hrow-20210331_lab.xml EX-101.LAB 495749
9 XBRL PRESENTATION FILE hrow-20210331_pre.xml EX-101.PRE 408327
10 EXTRACTED XBRL INSTANCE DOCUMENT form10-q_htm.xml XML 1007835
Mailing Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215
Business Address 102 WOODMONT BLVD SUITE 610 NASHVILLE TN 37215 615.733.4731
HARROW HEALTH, INC. (Filer) CIK: 0001360214 (see all company filings)

IRS No.: 450567010 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35814 | Film No.: 21911737
SIC: 2834 Pharmaceutical Preparations